secwatch.observer — SEC 8-K summary
======================================

Issuer:     CHEMED CORP (CHE)
CIK:        0000019584
Form:       8-K
Filed at:   2021-07-27T23:59:59+00:00
Accession:  0000019584-21-000011
Event type: earnings
Sentiment:  positive
Materiality: 0.75
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Chemed Q2 adj. EPS $4.60 (+4.3% YoY); Roto-Rooter revenue +26.1%; full-year guidance raised to $18.20-$18.50
--------------------------------------------------------------------------------

- Consolidated revenue $532M (+6.0%); GAAP diluted EPS $3.51 (-29.9%); adjusted diluted EPS $4.60 (+4.3%).
- VITAS net patient revenue $312M (-4.7%); ADC 17,995 (-6.3%); adjusted EBITDA margin ex-Medicare Cap 17.4% (-430bps).
- Roto-Rooter revenue $220M (+26.1%); adjusted EBITDA margin 29.2% (+236bps); residential +23.7%, commercial +31.8%.
- Full-year 2021 adjusted EPS guidance raised to $18.20-$18.50 from prior $17.00-$17.50; no debt, $92M cash.
- Company repurchased 250,000 shares for $122M during Q2; $312M remaining authorization.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/19584/000001958421000011/0000019584-21-000011-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/19584/000001958421000011/che-20210727x8k.htm
  HTML page:      https://secwatch.observer/filing/0000019584-21-000011

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer